Benson AB, Venook AP, Al-Hawary MM et al (2018) Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16(7):852–871

Article  PubMed  PubMed Central  Google Scholar 

Rao S, Guren MG, Khan K et al (2021) Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32:1087–1100

Article  CAS  PubMed  Google Scholar 

Nigro ND, Vaitkevicius VK, Considine B (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17(3):354–356

Article  CAS  PubMed  Google Scholar 

Peiffert D, Tournier-Rangeard L, Gérard JP et al (2012) Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol 30(16):1941–1948

Article  CAS  PubMed  Google Scholar 

UKCCCR Anal Cancer Trial Working Party (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UK Co-ordinating Committee on Cancer Research. Lancet 348(9034):1049–1054

Article  Google Scholar 

Ajani JA, Winter KA, Gunderson LL et al (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299(16):1914–1921

Article  CAS  PubMed  Google Scholar 

Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15(5):2040–2049

Article  CAS  PubMed  Google Scholar 

Northover J, Glynne-Jones R, Sebag-Montefiore D et al (2010) Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer 102(7):1123–1128

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghouti L, Houvenaeghel G, Moutardier V et al (2005) Salvage abdominoperineal resection after failure of conservative treatment in anal epidermoid cancer. Dis Colon Rectum 48(1):16–22

Article  PubMed  Google Scholar 

Schiller DE, Cummings BJ, Rai S et al (2007) Outcomes of salvage surgery for squamous cell carcinoma of the anal canal. Ann Surg Oncol 14(10):2780–2789

Article  PubMed  Google Scholar 

Nilsson PJ, Svensson C, Goldman S et al (2002) Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 89(11):1425–1429

Article  CAS  PubMed  Google Scholar 

Mariani P, Ghanneme A, De la Rochefordière A et al (2008) Abdominoperineal resection for anal cancer. Dis Colon Rectum 51(10):1495–1501

Article  CAS  PubMed  Google Scholar 

Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med 342(11):792–800

Article  CAS  PubMed  Google Scholar 

Ajani JA, D’Amico TA, Bentrem DJ et al (2019) Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 17(7):855–883

Article  CAS  PubMed  Google Scholar 

Lordick F, Mariette C, Haustermans K et al (2016) Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5):v50–v57

Article  CAS  PubMed  Google Scholar 

Yamada K, Saiki Y, Komori K et al (2022) Characteristics of anal canal cancer in Japan. Cancer Med 11(14):2735–2743

Article  PubMed  PubMed Central  Google Scholar 

Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours, 8th edn. Wiley, New York

Google Scholar 

Gray RJ (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16(3):1141–1154

Article  Google Scholar 

Dignam JJ, Kocherginsky MN (2008) Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol 26(24):4027–4034

Article  PubMed  PubMed Central  Google Scholar 

Wasserstein RL, Schirm AL, Lazar NA (2019) Moving to a world beyond “p < 0.05.” Am Statist 73(1):1–19

Article  Google Scholar 

Chai CY, Tran Cao HS, Awad S et al (2018) Management of stage I squamous cell carcinoma of the anal canal. JAMA Surg 153(3):209–215

Article  PubMed  PubMed Central  Google Scholar 

Kole AJ, Stahl JM, Park HS et al (2017) Predictors of nonadherence to NCCN guideline recommendations for the management of stage I anal canal cancer. J Natl Compr Canc Netw 15(3):355–362

Article  PubMed  Google Scholar 

Ortholan C, Resbeut M, Hannoun-Levi JM et al (2012) Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 study). Int J Radiat Oncol Biol Phys 82(5):1988–1995

Article  PubMed  Google Scholar 

Shepherd NA, Scholefield JH, Love SB et al (1990) Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases. Histopathology 16(6):545–555

Article  CAS  PubMed  Google Scholar 

Lin ACH, Hakim A, Kellish AS et al (2020) Inguinal lymph node dissection does not improve overall survival in anal cancer nodal disease. J Surg Res 255:13–22

Article  PubMed  Google Scholar 

Doyen J, Benezery K, Follana P et al (2013) Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy. Dis Colon Rectum 56(10):1125–1133

Article  PubMed  Google Scholar 

Devisetty K, Mell LK, Salama JK et al (2009) A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol 93(2):298–301

Article  PubMed  Google Scholar